Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.

Shiu Lun Ryan Au Yeung Catherine Mary Schooling

Published in: BMJ open diabetes research & care (2019)

Glycemic traits and type 2 diabetes unlikely cause breast and prostate cancer. Whether metformin can be repurposed for cancer prevention remains unclear.

Keyphrases

type diabetes
prostate cancer
glycemic control
radical prostatectomy
genome wide
cardiovascular disease
insulin resistance
papillary thyroid
squamous cell
skeletal muscle
dna methylation
young adults
lymph node metastasis